Testosterone cypionate

Drug Profile

Testosterone cypionate

Alternative Names: Andro-Cyp-100; Andro-Cyp-200; Andronaq-LA; Andronate; D-Tes 100; depAndro 100; depAndro 200; Depo; Depo-Testosterone; Depotest; Depotest 100; Depotest 200; Depovirin; Dura-Testosterone; Duratest; Duratest-100; Malogen Cyp; Man-Agin; Meditest; Pertestis; Shotest; T-Cypionate; Testa-C; Testadiate-Depo; Testaspan; Testergon; Testex Leo Prolongatum; Testodrin; Testoject; Testoject-100 LA; Testosterone cyclopentanepropionate; Testosterone cypionate; Testred Cypionate 200

Latest Information Update: 15 Jul 2015

Price : $50

At a glance

  • Originator Pfizer
  • Class Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Testosterone agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Andropause; Breast cancer; Breast disorders; Delayed puberty; Eunuchoidism; Hypogonadism; Oligospermia; Osteoporosis

Most Recent Events

  • 01 Jul 2014 Forest Laboratories has been acquired by Actavis Inc
  • 04 Jan 2007 Schwarz Pharma has been acquired by UCB
  • 26 Aug 2004 Aventis has merged with Sanofi-Synthelabo to form Sanofi-Aventis
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top